CE-123

Last updated
CE-123
CE-123 Structure.svg
(S)-CE-123
Clinical data
Other names(S)-CE-123; S-CE-123
Legal status
Legal status
Identifiers
  • (S)-5-(benzhydrylsulfinylmethyl)-1,3-thiazole
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C17H15NOS2
Molar mass 313.43 g·mol−1
3D model (JSmol)
  • O=S(Cc1cncs1)C(c2ccccc2)c3ccccc3
  • InChI=1S/C17H15NOS2/c19-21(12-16-11-18-13-20-16)17(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-11,13,17H,12H2
  • Key:VBBBWHDWYLUSEL-UHFFFAOYSA-N

CE-123, or as the active enantiomer (S)-CE-123, is an analog of modafinil, the most researched of a series of structurally related heterocyclic derivatives. [1] [2] [3] In animal studies, CE-123 was found to improve performance on tests of learning and memory in a manner consistent with a nootropic effect profile. [4] [5] [6] [7] (S)-CE-123 has pro-motivational effects in animals, reverses tetrabenazine-induced motivational deficits, and could be useful in the treatment of motivational disorders in humans. [8] [9]

See also

References

  1. ↑ Sase A, Aher YD, Saroja SR, Ganesan MK, Sase S, Holy M, et al. (March 2016). "A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes". Neuropharmacology. 102: 186–96. doi:10.1016/j.neuropharm.2015.07.039. PMID   26407764. S2CID   19840397.
  2. ↑ Saroja SR, Aher YD, Kalaba P, Aher NY, Zehl M, Korz V, et al. (October 2016). "A novel heterocyclic compound targeting the dopamine transporter improves performance in the radial arm maze and modulates dopamine receptors D1-D3". Behavioural Brain Research. 312: 127–37. doi:10.1016/j.bbr.2016.06.011. PMID   27288589. S2CID   38509577.
  3. ↑ Hussein AM, Aher YD, Kalaba P, Aher NY, Dragačević V, Radoman B, et al. (August 2017). "A novel heterocyclic compound improves working memory in the radial arm maze and modulates the dopamine receptor D1R in frontal cortex of the Sprague-Dawley rat". Behavioural Brain Research. 332: 308–315. doi:10.1016/j.bbr.2017.06.023. PMID   28629964. S2CID   205895268.
  4. ↑ Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, et al. (2017). "A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats". Frontiers in Behavioral Neuroscience. 11 222. doi: 10.3389/fnbeh.2017.00222 . PMC   5711856 . PMID   29230168.
  5. ↑ Kristofova M, Aher YD, Ilic M, Radoman B, Kalaba P, Dragacevic V, et al. (May 2018). "A daily single dose of a novel modafinil analogue CE-123 improves memory acquisition and memory retrieval". Behavioural Brain Research. 343: 83–94. doi:10.1016/j.bbr.2018.01.032. PMID   29410048. S2CID   3551334.
  6. ↑ Camats-Perna J, Kalaba P, Ebner K, Sartori SB, Vuyyuru H, Aher NY, et al. (2019). "Differential Effects of Novel Dopamine Reuptake Inhibitors on Interference With Long-Term Social Memory in Mice". Frontiers in Behavioral Neuroscience. 13 63. doi: 10.3389/fnbeh.2019.00063 . PMC   6470289 . PMID   31031603.
  7. ↑ Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, et al. (2019). "(S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding". Frontiers in Pharmacology. 10: 682. doi: 10.3389/fphar.2019.00682 . PMC   6611521 . PMID   31316379.
  8. ↑ Salamone JD, Correa M (January 2024). "The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine". Annu Rev Psychol. 75: 1–32. doi:10.1146/annurev-psych-020223-012208. hdl: 10234/207207 . PMID   37788571.
  9. ↑ Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, Wackerlig J, Langer T, Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, Correa M, Lubec G, Salamone JD (2019). "The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding". Front Pharmacol. 10 682. doi: 10.3389/fphar.2019.00682 . PMC   6611521 . PMID   31316379.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.